Partner Headlines - PGNX

  1. Earnings Scheduled For March 13, 2014

    Benzinga
  2. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  3. Progenics Pharmaceuticals Announces the Appointment of Karen ...

    Benzinga
  4. Progenics Pharmaceuticals Relaunches Registrational Trial of ...

    Benzinga
  5. Earnings Scheduled For November 11, 2013

    Benzinga
  6. Salix Pharmaceuticals Thrives With Promising GI Drugs

    IBD
  7. Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX

    GuruFocus
  8. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  9. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  10. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  11. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  12. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  13. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  14. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  15. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  16. Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX

    GuruFocus
  17. Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Robert Baker buys ...

    GuruFocus
  18. 5 Stocks That Dropped the Most Since Gurus Bought Them

    GuruFocus
  19. EZchip Semiconductor, Sagent Pharmaceuticals Among Stocks setting ...

    FoxBusiness
  20. Salix trounces Q2 estimates

    IBD
  21. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  22. Salix Pharmaceuticals Beats, Announces Licensing Deal

    IBD
  23. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily ...

    FoxBusiness
  24. Stocks Finish Little Changed Ahead of Central Bank Meetings with ...

    MarketIntelligenceCenter
  25. Salix, Progenics Stocks Fall On Drug Approval Delay

    IBD
  26. Stock Futures Mixed; Salix, Progenics Tumble

    IBD
  27. Benzinga's Top Pre-Market Losers

    Benzinga
  28. Financial Breakfast: Morning News Summary for July 30, 2012

    Benzinga
  29. Salix Q1 Results Beat Estimates; Raises EPS Guidance

    IBD
  30. Microcap Movers for Tuesday December 20, 2011

    Benzinga
  31. Stocks Bounce Back In Big Volume

    IBD
  32. Progenics Pharma Up 30% on Positive Phase 3 Results

    Benzinga
  33. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
  34. Morning Market Movers

    Benzinga
  35. Progenics Pharmaceuticals Lures Call Players in the Options Pits

    SchaeffersResearch
  36. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
Trading Center